NetraMark Holdings (AIAI.C): Failed FDA trials cost billions, NetraAI may prevent them
NetraMark's approach aligns with what many in the industry say they want – more precision, more use of AI , fewer failures . The challenge is ...
Read the original at Equity.Guru ↗
- Topics
- Healthcare
- Mentions
- FDA
- Tracked via
- “AI Falures”